Cargando…
Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials
OBJECTIVE: Insulin analogs are increasingly used in patients with type 2 diabetes. We compared the effect of basal, biphasic, prandial, and basal-bolus insulin regimens with insulin analogs to reach the hemoglobin A(1c) (HbA(1c)) target of <7% in people with type 2 diabetes. RESEARCH DESIGN AND M...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024378/ https://www.ncbi.nlm.nih.gov/pubmed/21216850 http://dx.doi.org/10.2337/dc10-1710 |
_version_ | 1782196776756838400 |
---|---|
author | Giugliano, Dario Maiorino, Maria Ida Bellastella, Giuseppe Chiodini, Paolo Ceriello, Antonio Esposito, Katherine |
author_facet | Giugliano, Dario Maiorino, Maria Ida Bellastella, Giuseppe Chiodini, Paolo Ceriello, Antonio Esposito, Katherine |
author_sort | Giugliano, Dario |
collection | PubMed |
description | OBJECTIVE: Insulin analogs are increasingly used in patients with type 2 diabetes. We compared the effect of basal, biphasic, prandial, and basal-bolus insulin regimens with insulin analogs to reach the hemoglobin A(1c) (HbA(1c)) target of <7% in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: We conducted an electronic search for randomized controlled trials (RCTs) involving insulin analogs. RCTs were included if they lasted at least 12 weeks, reported the proportion of diabetic patients reaching the HbA(1c) target of <7% (primary outcome), and the number of patients in any arm was >30. RESULTS: We found 16 RCTs, with 20 comparisons and 7,759 patients. A greater proportion of patients achieved the HbA(1c) goal of <7% with both biphasic (odds ratio 1.88 [95% CI 1.38–2.55]) and prandial (2.07 [1.16–3.69]) insulin compared with basal insulin; this was associated for biphasic insulin with greater hypoglycemia (event/patient/30 days, mean difference, 0.34 [range 0–0.69]) and weight gain in kg (1.0 kg [0.28–1.73]). Compared with biphasic insulin, the basal-bolus regimen was associated with a greater chance to reach the HbA(1c) goal (odds ratio 1.75 [95% CI 1.11–2.77]), with no greater hypoglycemia or weight gain. The effect of insulin analogs on long-term diabetes complications is still lacking. CONCLUSIONS: A greater proportion of type 2 diabetic patients can achieve the HbA(1c) goal <7% with biphasic or prandial insulin compared with basal insulin; in absolute terms, the basal-bolus regimen was best for the attainment of the HbA(1c) goal. |
format | Text |
id | pubmed-3024378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-30243782012-02-01 Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials Giugliano, Dario Maiorino, Maria Ida Bellastella, Giuseppe Chiodini, Paolo Ceriello, Antonio Esposito, Katherine Diabetes Care Reviews/Commentaries/ADA Statements OBJECTIVE: Insulin analogs are increasingly used in patients with type 2 diabetes. We compared the effect of basal, biphasic, prandial, and basal-bolus insulin regimens with insulin analogs to reach the hemoglobin A(1c) (HbA(1c)) target of <7% in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: We conducted an electronic search for randomized controlled trials (RCTs) involving insulin analogs. RCTs were included if they lasted at least 12 weeks, reported the proportion of diabetic patients reaching the HbA(1c) target of <7% (primary outcome), and the number of patients in any arm was >30. RESULTS: We found 16 RCTs, with 20 comparisons and 7,759 patients. A greater proportion of patients achieved the HbA(1c) goal of <7% with both biphasic (odds ratio 1.88 [95% CI 1.38–2.55]) and prandial (2.07 [1.16–3.69]) insulin compared with basal insulin; this was associated for biphasic insulin with greater hypoglycemia (event/patient/30 days, mean difference, 0.34 [range 0–0.69]) and weight gain in kg (1.0 kg [0.28–1.73]). Compared with biphasic insulin, the basal-bolus regimen was associated with a greater chance to reach the HbA(1c) goal (odds ratio 1.75 [95% CI 1.11–2.77]), with no greater hypoglycemia or weight gain. The effect of insulin analogs on long-term diabetes complications is still lacking. CONCLUSIONS: A greater proportion of type 2 diabetic patients can achieve the HbA(1c) goal <7% with biphasic or prandial insulin compared with basal insulin; in absolute terms, the basal-bolus regimen was best for the attainment of the HbA(1c) goal. American Diabetes Association 2011-02 2011-01-20 /pmc/articles/PMC3024378/ /pubmed/21216850 http://dx.doi.org/10.2337/dc10-1710 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Reviews/Commentaries/ADA Statements Giugliano, Dario Maiorino, Maria Ida Bellastella, Giuseppe Chiodini, Paolo Ceriello, Antonio Esposito, Katherine Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials |
title | Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials |
title_full | Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials |
title_fullStr | Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials |
title_full_unstemmed | Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials |
title_short | Efficacy of Insulin Analogs in Achieving the Hemoglobin A(1c) Target of <7% in Type 2 Diabetes: Meta-analysis of randomized controlled trials |
title_sort | efficacy of insulin analogs in achieving the hemoglobin a(1c) target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials |
topic | Reviews/Commentaries/ADA Statements |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024378/ https://www.ncbi.nlm.nih.gov/pubmed/21216850 http://dx.doi.org/10.2337/dc10-1710 |
work_keys_str_mv | AT giuglianodario efficacyofinsulinanalogsinachievingthehemoglobina1ctargetof7intype2diabetesmetaanalysisofrandomizedcontrolledtrials AT maiorinomariaida efficacyofinsulinanalogsinachievingthehemoglobina1ctargetof7intype2diabetesmetaanalysisofrandomizedcontrolledtrials AT bellastellagiuseppe efficacyofinsulinanalogsinachievingthehemoglobina1ctargetof7intype2diabetesmetaanalysisofrandomizedcontrolledtrials AT chiodinipaolo efficacyofinsulinanalogsinachievingthehemoglobina1ctargetof7intype2diabetesmetaanalysisofrandomizedcontrolledtrials AT cerielloantonio efficacyofinsulinanalogsinachievingthehemoglobina1ctargetof7intype2diabetesmetaanalysisofrandomizedcontrolledtrials AT espositokatherine efficacyofinsulinanalogsinachievingthehemoglobina1ctargetof7intype2diabetesmetaanalysisofrandomizedcontrolledtrials |